RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$913M
AUM Growth
+$115M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
108
New
Increased
Reduced
Closed

Top Buys

1
+$9.4M
2
+$9.14M
3
+$7.09M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.8M
5
COO icon
Cooper Companies
COO
+$6.43M

Top Sells

1
+$12.1M
2
+$12M
3
+$11.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$11.1M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.05M

Sector Composition

1 Healthcare 93.54%
2 Financials 0.09%
3 Energy 0.09%
4 Technology 0.09%
5 Communication Services 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$7.55M 0.83%
370,000
+150,000
52
$7.49M 0.82%
65,000
+53,033
53
$7.09M 0.78%
+36,000
54
$6.99M 0.77%
60,715
-8,285
55
$6.96M 0.76%
263,400
-272,257
56
$6.8M 0.75%
+125,000
57
$6.43M 0.7%
+80,000
58
$6.18M 0.68%
1,080,000
-154,335
59
$5.93M 0.65%
+20,000
60
$5.86M 0.64%
700,000
-34,811
61
$5.68M 0.62%
+65,000
62
$5.3M 0.58%
100,000
+30,000
63
$5.02M 0.55%
150,000
+799
64
$5M 0.55%
4,400
+386
65
$4.96M 0.54%
40,000
-7,600
66
$4.3M 0.47%
+60,000
67
$4.07M 0.45%
190,000
-10,000
68
$4.06M 0.44%
250,000
+76,083
69
$3.9M 0.43%
140,000
-2,126
70
$3.83M 0.42%
+191,300
71
$3.61M 0.4%
50,000
+30,000
72
$3.51M 0.39%
+178,073
73
$3.43M 0.38%
170,000
+20,000
74
$3.31M 0.36%
+20,000
75
$3.27M 0.36%
40,000
1 2
3
4 5